ConductScience.org, home

Paper810797

Acetylation of prostaglandin synthase by aspirin.

Roth GJ and 2 others. Proc Natl Acad Sci U S A, 1975. Cited by 1,028 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Acetylation of prostaglandin synthase by aspirin. Papers, record 810797. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/810797

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Acetylation of prostaglandin synthase by aspirin.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1975
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,028
iCite
Relative citation ratio, by iCite
28
iCite
Revised in PubMed
2019-05-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Roth GJG J
2Stanford NN
3Majerus PWP W

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AspirinMajor topic
Mixed Function OxygenasesMajor topic
Prostaglandin-Endoperoxide SynthasesMajor topic
Acetylation
Animals
Arachidonic Acids
Blood Platelets
Cattle
Chemical Phenomena
Chemistry
Fatty Acids, Nonesterified
Humans
Indomethacin
Kinetics
Male
Microsomes
Molecular Weight
Seminal Vesicles

Source PubMed

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00272311Aspirin Dose and Atherosclerosis in Patients With Metabolic SyndromeBackgroundClinicalTrials.gov
NCT00272337Aspirin Dose and Atherosclerosis in Patients With Heart DiseaseBackgroundClinicalTrials.gov

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,215,079Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets.Proc Natl Acad Sci U S A1974https://conductscience.org/library/papers/4215079PubMed
24,560,273Biosynthesis of prostaglandins.Fed Proc1972https://conductscience.org/library/papers/4560273PubMed
34,514,999Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis.Proc Natl Acad Sci U S A1973https://conductscience.org/library/papers/4514999PubMed
44,521,806Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.Proc Natl Acad Sci U S A1974https://conductscience.org/library/papers/4521806PubMed
54,530,264Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins.Proc Natl Acad Sci U S A1974https://conductscience.org/library/papers/4530264PubMed
64,856,851Inhibition of sheep vesicular gland oxygenase by unsaturated fatty acids from skin of essential fatty acid deficient rats.Prostaglandins1974https://conductscience.org/library/papers/4856851PubMed
74,856,653The binding of thrombin to the surface of human platelets.J Biol Chem1974https://conductscience.org/library/papers/4856653PubMed
84,809,076An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin.Science1974https://conductscience.org/library/papers/4809076PubMed
94,173,352In vitro acetylation of plasma proteins, enzymes and DNA by aspirin.Nature1968https://conductscience.org/library/papers/4173352PubMed
104,989,543Inhibition of prostaglandin biosynthesis by 8cis, 12trans, 14cis-eicosatrienoic acid and 5cis, 8cis, 12trans, 14cis-eicosatetraenoic acid.Biochim Biophys Acta1970https://conductscience.org/library/papers/4989543PubMed
115,284,361Aspirin selectively inhibits prostaglandin production in human platelets.Nat New Biol1971https://conductscience.org/library/papers/5284361PubMed
125,284,360Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.Nat New Biol1971https://conductscience.org/library/papers/5284360PubMed
134,215,082Prostaglandin synthetase system--resolution into oxygenase and isomerase components.Proc Natl Acad Sci U S A1974https://conductscience.org/library/papers/4215082PubMed
144,783,568Quantitative determination of prostaglandins and malondialdehyde formed by the arachidonate oxygenase (prostaglandin synthetase) system of bovine seminal vesicle.Prostaglandins1973https://conductscience.org/library/papers/4783568PubMed
154,996,821Properties of a novel preparation of prostaglandin synthetase from sheep seminal vesicles.Biochim Biophys Acta1971https://conductscience.org/library/papers/4996821PubMed
165,132,680Stimulation and blockade of prostaglandin biosynthesis.J Biol Chem1971https://conductscience.org/library/papers/5132680PubMed
175,114,995Mechanism of prostaglandin biosynthesis. I. Characterization and assay of bovine prostaglandin synthetase.Biochemistry1971https://conductscience.org/library/papers/5114995PubMed
185,425,364Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets.J Lab Clin Med1970https://conductscience.org/library/papers/5425364PubMed
195,773,090Structural changes in human serum albumin induced by ingestion of acetylsalicylic acid.J Clin Invest1969https://conductscience.org/library/papers/5773090PubMed
205,660,093Inhibition of prostaglandin synthesis by oleic, linoleic and linolenic acids.Biochim Biophys Acta1968https://conductscience.org/library/papers/5660093PubMed

Cited by227

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,028 citations.

PMIDTitleJournalYearIn PapersSource
42,765,007Tocotrienol metabolites redirect lipid mediator production in innate immune cells towards inflammation resolution.Acta Pharm Sin B2026https://conductscience.org/library/papers/42765007PubMed
42,664,449First-24-hour aspirin exposure and 28-day mortality in critically ill adults with cerebral embolism: A retrospective MIMIC-IV cohort study.Sci Prog2026https://conductscience.org/library/papers/42664449PubMed
42,653,726Development of a PK/PD-Efficacy Modeling Framework for Covalent Inhibitors.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42653726PubMed
41,912,748Aspirin in Colorectal Cancer Care: Who to Treat, When, and Why.Curr Oncol Rep2026https://conductscience.org/library/papers/41912748PubMed
39,996,767Salicylate-Elicited Activation of AMP-Activated Protein Kinase Directly Triggers Degradation of C-Myc in Colorectal Cancer Cells.Cells2025https://conductscience.org/library/papers/39996767PubMed
39,598,130Severity of Acute Kawasaki Disease Can Be Predicted by Evaluating the Body Temperature at the Completion of an Initial Immunoglobulin Treatment.J Clin Med2024https://conductscience.org/library/papers/39598130PubMed
39,465,093The Impact of TBXA2R Gene Variants on the Risk of Aspirin-Induced Upper Gastrointestinal Bleeding: A Case-Control Study.Hosp Pharm2024https://conductscience.org/library/papers/39465093PubMed
39,435,035Pharmacogenomics revolutionizing cardiovascular therapeutics: A narrative review.Health Sci Rep2024https://conductscience.org/library/papers/39435035PubMed
39,268,466The future of pharmacology and therapeutics of the arachidonic acid cascade in the next decade: Innovative advancements in drug repurposing.Front Pharmacol2024https://conductscience.org/library/papers/39268466PubMed
39,138,742Thromboxane A2 blockade attenuates ethanol-induced myocardial inflammation: Sipping from the same bottle.Alcohol Clin Exp Res (Hoboken)2024https://conductscience.org/library/papers/39138742PubMed
39,063,598Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).Life (Basel)2024https://conductscience.org/library/papers/39063598PubMed
38,542,492Electrophilic Compounds in the Human Diet and Their Role in the Induction of the Transcription Factor NRF2.Int J Mol Sci2024https://conductscience.org/library/papers/38542492PubMed
37,894,903Computational Investigations on Reaction Mechanisms of the Covalent Inhibitors Ponatinib and Analogs Targeting the Extracellular Signal-Regulated Kinases.Int J Mol Sci2023https://conductscience.org/library/papers/37894903PubMed
37,305,209An update on the discovery and development of reversible covalent inhibitors.Med Chem Res2023https://conductscience.org/library/papers/37305209PubMed
36,720,071Prostaglandin E2 Production by Brain Endothelial Cells and the Generation of Fever.DNA Cell Biol2023https://conductscience.org/library/papers/36720071PubMed
36,561,076Advanced approaches of developing targeted covalent drugs.RSC Med Chem2022https://conductscience.org/library/papers/36561076PubMed
36,546,455Reduced platelet glycoprotein Ibα shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen.Haematologica2023https://conductscience.org/library/papers/36546455PubMed
36,406,033Anticoagulation and Antiplatelet Agents in Peripheral Arterial Interventions.Semin Intervent Radiol2022https://conductscience.org/library/papers/36406033PubMed
36,285,735Applications of covalent chemistry in targeted protein degradation.Chem Soc Rev2022https://conductscience.org/library/papers/36285735PubMed
36,189,951Fifty years with aspirin and platelets.Br J Pharmacol2023https://conductscience.org/library/papers/36189951PubMed

See all 227 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/810797

GET https://conductscience.org/api/papers/v1/810797/cited_by?page=2